Analysis of IJT Stock's 52-Week Performance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy SANM?
Source: NASDAQ.COM
- Price Range Analysis: IJT's stock has a 52-week low of $107.38 and a high of $154.71, with the last trade at $141.10, indicating a relatively stable market performance that may attract investor interest.
- Technical Analysis Tool: Comparing the current stock price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment and timing of investments.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on investor demand, reflecting changes in market liquidity.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing significant inflows or outflows, allowing investors to assess the impact on underlying assets and make more informed decisions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SANM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SANM
Wall Street analysts forecast SANM stock price to rise
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 124.030
Low
180.00
Averages
180.00
High
180.00
Current: 124.030
Low
180.00
Averages
180.00
High
180.00
About SANM
Sanmina Corporation is a global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. It provides end-to-end manufacturing solutions, delivering support to original equipment manufacturers in the industrial and energy, medical, defense and aerospace, automotive and transportation, communications networks and cloud and artificial intelligence infrastructure industries. Its operations are managed in two businesses: Integrated Manufacturing Solutions (IMS) and Components, Products and Services (CPS). IMS segment consists of printed circuit board assembly and test, high-level assembly and test and direct-order-fulfillment. CPS includes advanced printed circuit boards, backplanes and backplane assemblies, cable assemblies, fabricated metal parts, precision machined parts and plastic injected molded parts. Its products include optical, radio frequency and microelectronic design and manufacturing services, among others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Price Range Analysis: IJT's stock has a 52-week low of $107.38 and a high of $154.71, with the last trade at $141.10, indicating a relatively stable market performance that may attract investor interest.
- Technical Analysis Tool: Comparing the current stock price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment and timing of investments.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on investor demand, reflecting changes in market liquidity.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing significant inflows or outflows, allowing investors to assess the impact on underlying assets and make more informed decisions.
See More
- Valuation Tool Comparison: While the price-to-earnings (P/E) ratio is popular among investors, the EV-to-EBITDA ratio is considered superior due to its comprehensive valuation approach, particularly in assessing potential acquisition targets, as it better reflects a company's true value and earnings potential.
- Industry Performance Variance: The EV-to-EBITDA ratio varies significantly across industries, with high-growth sectors typically exhibiting higher multiples, thus caution is advised when making cross-industry comparisons to avoid misleading investment decisions.
- Company Growth Expectations: Eni S.p.A. anticipates a year-over-year growth rate of 10.3% for 2026, while Sanmina Corp. boasts an impressive expected growth rate of 66.5%, and FirstSun Capital Bancorp and First American Financial Corp. project growth rates of 13.8% and 5%, respectively, indicating strong future profitability potential for these firms.
- Investment Strategy Recommendation: Investors are advised to combine EV-to-EBITDA with other major valuation ratios such as price-to-book (P/B) and price-to-sales (P/S) to comprehensively screen for value stocks, thereby enhancing the likelihood of investment success.
See More

Market Opening: U.S. stock markets are set to open in two hours.
Evolution Metals & Technologies Corp. Performance: EMAT saw a significant increase of 21.9% in pre-market trading.
Keysight Technologies Inc. Performance: KEYS experienced a rise of 15.2% in pre-market trading.
Overall Market Sentiment: The pre-market gains indicate positive investor sentiment ahead of the market opening.
See More
- Strong Earnings: Sanmina reported nearly $3.19 billion in net sales for Q1 FY2026, a significant increase from just over $2 billion last year, highlighting the company's robust growth potential in the AI market.
- Profit Growth: The company’s non-GAAP net income exceeded $132 million ($2.38 per share), surpassing analyst expectations of $2.14 per share, indicating improved profitability.
- Negative Market Reaction: Despite beating estimates, investors reacted negatively to the company's weak guidance, resulting in a nearly 22% drop in stock price, reflecting a disconnect between high market expectations and actual performance.
- Cautious Outlook: Sanmina projects Q2 net sales between $3.1 billion and $3.4 billion; although the adjusted EPS forecast exceeds the average analyst estimate, the market's expectation for higher sales figures indicates investor concerns about future performance.
See More
- S&P 500 Hits All-Time High: The S&P 500 index rose 0.41% on Tuesday, achieving a new all-time high, reflecting strong market confidence in tech stocks and chipmakers, particularly after Micron Technology announced a $24 billion investment in Singapore to expand memory chip capacity.
- Nasdaq Performance Strong: The Nasdaq 100 index increased by 0.88%, reaching a 2.75-month high, indicating investor optimism in AI infrastructure and semiconductor sectors, which propelled the broader market higher.
- Consumer Confidence Index Declines: Despite the stock market gains, the US January consumer confidence index unexpectedly fell to an 11.5-year low of 84.5, highlighting economic uncertainty that could negatively impact future consumer spending.
- Health Insurance Stocks Under Pressure: The proposal by the US government to keep payments to private Medicare plans flat next year led to a broad decline in health insurance stocks, with UnitedHealth Group forecasting a revenue contraction in 2026, marking the first annual decline in over 30 years, raising further market concerns.
See More
- Tech Stock Surge: The Nasdaq 100 index rose by 0.87%, reaching a 2.75-month high, primarily driven by strength in chipmakers and AI infrastructure stocks, indicating strong market confidence in the tech sector.
- Micron's Investment Plan: Micron Technology announced a $24 billion investment in Singapore to expand memory chip capacity, leading to a 5% stock price increase, which not only enhances its competitive position but may also stimulate growth in the related supply chain.
- Consumer Confidence Decline: Despite the stock market gains, the US January consumer confidence index unexpectedly fell to an 11.5-year low of 84.5, indicating economic uncertainty that could negatively impact consumer spending.
- Health Insurance Stocks Under Pressure: The proposed flat payments for private Medicare plans led UnitedHealth Group's stock to drop over 19%, marking the first expected revenue decline in over 30 years, reflecting the policy risks facing the healthcare sector.
See More










